title: Impact of National and International Stem Cell Banking Initiatives on progress in the field of cell therapy: IABS-JST Joint Workshop: Summary for Session 5.
abstract: In order to assure the quality and safety of future advanced cell therapies it is vital to ensure that source materials including the donor cells have been assessed and demonstrated as suitable for use in the development and manufacture of such new medicines. Here we provide a brief overview of the key issues in the delivery of quality controlled and safety tested seed stocks of human pluripotent stem cell lines to support stem cell research and the development of advanced cell therapies. We also reflect on the importance of national and internationally coordinated cell banking systems in this process in order to promote more efficient development of cell therapies.
authors: Department of iPS Cell Applications, Graduate School of Medicine, Kobe University, Kobe, Japan.
authors: Takashi
authors: T
authors: Aoi
authors: UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control, A Centre of The Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK. Electronic address: glyn.stacey@nibsc.org.
authors: Glyn
authors: G
authors: Stacey
mesh_terms: D064987:Cell- and Tissue-Based Therapy; D006801:Humans; D007391:International Cooperation; D013234:Stem Cells; D014015:Tissue Banks
keywords: Bio-banking; Cell therapy; Quality control; Regenerative medicines; hESC; iPSC